IL4 and breast carcinoma: Meanwhile, through MetaCore and TIMER analysis revealed that “Immune response_IL-4-induced regulators of cell growth, survival, differentiation and metabolism”, and immune-related pathways were correlated with GLUL expression in breast cancer patients from TCGA and METABRIC datasets.